Furthermore, lymphomas, myelomas and leukemias may show genetic alterations of genes encoding for NF-κB subunits or other genes of the NF-κB signaling pathway leading to significant changes in NF-κB expression or activity [34,35,36]. The gene discussed is NFKB1; the disease is plasma cell myeloma.